Clinical Trial Update: Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the bioequivalence of two formulations of tamsulosin hydrochloride capsules in fed male participants with prostatic hyperplasia; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Tamsulosin HCl capsules (tamsulosin hydrochloride)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Phase 1 | Status: COMPLETED | Results posted: 2020-04-17